Lineage Cell Therapeutics
LCTX
#8727
Rank
S$0.16 B
Marketcap
$0.74
Share price
9.51%
Change (1 day)
-47.73%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -S$30.27 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are S$8.71 Million. In 2023 the company made an earning of -S$33.56 Million a decrease over its 2022 earnings that were of -S$30.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$30.27 Million-9.81%
2023 -S$33.56 Million9.83%
2022 -S$30.56 Million-54.24%
2021 -S$66.77 Million86.07%
2020 -S$35.89 Million-31.97%
2019 -S$52.75 Million-5.42%
2018 -S$55.77 Million1.1%
2017 -S$55.17 Million-31.06%
2016 -S$80.01 Million-10.38%
2015 -S$89.29 Million29.69%
2014 -S$68.85 Million31.68%
2013 -S$52.29 Million
2011 -S$25.38 Million89.78%
2010 -S$13.37 Million206.06%
2009 -S$4.37 Million-0.58%
2008 -S$4.4 Million164.89%
2007 -S$1.66 Million-30.22%
2006 -S$2.38 Million
2002 -S$2.77 Million-41.04%
2001 -S$4.69 Million-32.04%
2000 -S$6.89 Million-11.85%
1999 -S$7.82 Million
1997 -S$5.03 Million12.12%
1996 -S$4.48 Million106.25%
1995 -S$2.18 Million-11.11%
1994 -S$2.45 Million50%
1993 -S$1.63 Million20%
1992 -S$1.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.19 Billion 492.84%๐Ÿ‡บ๐Ÿ‡ธ USA